CK

Conductive Keratoplasty (CK) received FDA approval on 2002. This procedure is indicated for the temporary reduction of farsightedness (between +0.75 to +3.25 diopters) in those 40 years of age or older.

CK uses radiofrequency energy to shrink collagen tissue within the cornea to treat low to moderate farsightedness and presbyopia. Using a controlled release of radiofrequency energy into the stroma (the third layer of cornea), the temperature of the corneal tissue is increased, which makes the cornea steeper and increases its focusing power. The procedure is performed in approximately 3 minutes per eye.

CK is a suitable alternative of treatment for patients who want to reduce or eliminate their dependence on glasses, reading glasses or contacts for close vision, and have not had previous correction surgery.